The market's inefficiency during erratic price movements creates opportunities to invest in fundamentally sound stocks. Read ...

ResMed Inc.’s RMD adjusted earnings per share (EPS) in the third quarter of fiscal 2025 were $2.37, up 11.3% year over year. The metric beat the Zacks Consensus Estimate by 0.4%. (Find the latest EPS ...

Gold is higher, as worries over tariffs affecting economic growth see a flight to safety. Despite likely slower global growth ...

Despite a forward P/E of 83.1x, Tesla’s high valuation, mixed analyst sentiment, and insider selling suggest holding current ...